These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7522122)

  • 1. Prostate cancer screening. Appropriate choices? Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ
    Cancer; 1994 Oct; 74(7 Suppl):2016-22. PubMed ID: 7522122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Cancer Society's National Prostate Cancer Detection Project.
    Littrup PJ
    Can J Oncol; 1994 Nov; 4 Suppl 1():65-9. PubMed ID: 8853493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC; Mettlin CJ; Murphy GP
    J Urol; 1994 Nov; 152(5 Pt 2):1873-7. PubMed ID: 7523734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC; Mettlin CJ
    CA Cancer J Clin; 1993; 43(3):134-49. PubMed ID: 7683964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ; Kane RA; Mettlin CJ; Murphy GP; Lee F; Toi A; Badalament R; Babaian R
    Cancer; 1994 Dec; 74(12):3146-58. PubMed ID: 7526969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A
    Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
    Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer. A decision analytic view.
    Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
    JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening in a large corporation population.
    Kantrowitz W; Doyle J; Semeraro J; Krane RJ
    J Occup Environ Med; 1995 Oct; 37(10):1193-8. PubMed ID: 8542338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of prostate cancer early detection.
    Mettlin C
    Cancer; 1993 Aug; 72(3 Suppl):1050-5. PubMed ID: 7687518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The socioeconomic implications of prostate-specific antigen screening.
    Benoit RM; Naslund MJ
    Urol Clin North Am; 1997 May; 24(2):451-8. PubMed ID: 9126243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Waldman AR; Osborne DM
    Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen in screening of prostate cancer.
    Chu TM
    J Clin Lab Anal; 1994; 8(5):323-6. PubMed ID: 7528795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.
    Mettlin C; Lee F; Drago J; Murphy GP
    Cancer; 1991 Jun; 67(12):2949-58. PubMed ID: 1710531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economics of prostate cancer screening.
    Benoit RM; Naslund MJ
    Oncology (Williston Park); 1997 Oct; 11(10):1533-43; discussion 1543, 1547-8. PubMed ID: 9348558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.